Update on serologic testing in COVID–19

Serologic tests are one of the available diagnostic tools in COVID–19. Growing literature highlights their role in the clinical management of the disease. Unfortunately, due to the limited availability of commercial tests and the lack of reliable trials establishing the sensitivity and specificity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajewski, Rafał, Gołębiowska, Justyna, Makuch, Sebastian, Mazur, Grzegorz, Agrawal, Siddarth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491380/
https://www.ncbi.nlm.nih.gov/pubmed/32946795
http://dx.doi.org/10.1016/j.cca.2020.09.015
_version_ 1783582209434714112
author Krajewski, Rafał
Gołębiowska, Justyna
Makuch, Sebastian
Mazur, Grzegorz
Agrawal, Siddarth
author_facet Krajewski, Rafał
Gołębiowska, Justyna
Makuch, Sebastian
Mazur, Grzegorz
Agrawal, Siddarth
author_sort Krajewski, Rafał
collection PubMed
description Serologic tests are one of the available diagnostic tools in COVID–19. Growing literature highlights their role in the clinical management of the disease. Unfortunately, due to the limited availability of commercial tests and the lack of reliable trials establishing the sensitivity and specificity of the diagnostic method, the clinical application of the test needs to be precisely determined. In this paper, we discuss the utility of anti–SARS–CoV–2 serology testing in a clinical setting and propose diagnostic algorithms that include serological tests in patients with confirmed or suspected COVID–19.
format Online
Article
Text
id pubmed-7491380
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74913802020-09-16 Update on serologic testing in COVID–19 Krajewski, Rafał Gołębiowska, Justyna Makuch, Sebastian Mazur, Grzegorz Agrawal, Siddarth Clin Chim Acta Review Serologic tests are one of the available diagnostic tools in COVID–19. Growing literature highlights their role in the clinical management of the disease. Unfortunately, due to the limited availability of commercial tests and the lack of reliable trials establishing the sensitivity and specificity of the diagnostic method, the clinical application of the test needs to be precisely determined. In this paper, we discuss the utility of anti–SARS–CoV–2 serology testing in a clinical setting and propose diagnostic algorithms that include serological tests in patients with confirmed or suspected COVID–19. Elsevier B.V. 2020-11 2020-09-15 /pmc/articles/PMC7491380/ /pubmed/32946795 http://dx.doi.org/10.1016/j.cca.2020.09.015 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Krajewski, Rafał
Gołębiowska, Justyna
Makuch, Sebastian
Mazur, Grzegorz
Agrawal, Siddarth
Update on serologic testing in COVID–19
title Update on serologic testing in COVID–19
title_full Update on serologic testing in COVID–19
title_fullStr Update on serologic testing in COVID–19
title_full_unstemmed Update on serologic testing in COVID–19
title_short Update on serologic testing in COVID–19
title_sort update on serologic testing in covid–19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491380/
https://www.ncbi.nlm.nih.gov/pubmed/32946795
http://dx.doi.org/10.1016/j.cca.2020.09.015
work_keys_str_mv AT krajewskirafał updateonserologictestingincovid19
AT gołebiowskajustyna updateonserologictestingincovid19
AT makuchsebastian updateonserologictestingincovid19
AT mazurgrzegorz updateonserologictestingincovid19
AT agrawalsiddarth updateonserologictestingincovid19

Ejemplares similares